Personalized Medicine

October 2015, Vol 5, No 7

Foundation Medicine on a Molecular Level

Weighing Cost and Care: An Oncologist's Debate

Cancer is basically a disease of the genome. We know that most cancers are caused by changes at the DNA level, whether it’s caused by radiation, cigarette smoking, or unknown factors. DNA changes are really what drive cancer. Read More ›

By Andrew Stainthorpe, PhD

Personalizing Cancer Treatment Based on a Unique Genetic Profile

Cost is a societal factor in the provision of medicines. Oncologists should work in the best interests of their patients and provide the treatments that give patients the most benefit, the fewest side effects, and the best chances of survival. Read More ›

What Patients Really Want from Their Care Team

A large part of what we need to do at Foundation Medicine is educate the physician, and the patients, that a test like ours is available, today, to give them a full information about their DNA, and what drives the cancer. Read More ›

By Linda Bosserman, MD, FACP

Is Research Translating to Meaningful Treatment to Patients?

As an oncologist who’s practiced for 35 years in the community where I really know my patients, when you listen to patients, they want to be actively involved they and their family, or a combination. Read More ›

How to Better Establish Clinical Utility for Tests in Personalized Medicine

We’re getting there very quickly. One of the big questions is, “How do these research findings translate, as you say, to treatment for patients?” Read More ›